SignatureFD’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-395
| Closed | -$6K | – | 3455 |
|
|
2022
Q3 | $6K | Buy |
+395
| New | +$4.59K | ﹤0.01% | 2405 |
|
|
2022
Q2 | – | Sell |
-141
| Closed | -$1K | – | 3433 |
|
|
2022
Q1 | $1K | Buy |
+141
| New | +$1.09K | ﹤0.01% | 3108 |
|
|
2021
Q4 | – | Sell |
-67
| Closed | -$1K | – | 3345 |
|
|
2021
Q3 | $1K | Sell |
67
-88
| -57% | -$1.29K | ﹤0.01% | 2986 |
|
|
2021
Q2 | $2K | Buy |
+155
| New | +$2.66K | ﹤0.01% | 2652 |
|
|
2019
Q3 | – | Sell |
-125
| Closed | -$4K | – | 2241 |
|
|
2019
Q2 | $4K | Hold |
125
| – | – | ﹤0.01% | 1645 |
|
|
2019
Q1 | $6K | Hold |
125
| – | – | ﹤0.01% | 1560 |
|
|
2018
Q4 | $5K | Hold |
125
| – | – | ﹤0.01% | 1557 |
|
|
2018
Q3 | $8K | Hold |
125
| – | – | ﹤0.01% | 1449 |
|
|
2018
Q2 | $8K | Buy |
+125
| New | +$6.99K | ﹤0.01% | 1462 |
|
|
2016
Q4 | – | Sell |
-258
| Closed | -$10K | – | 1337 |
|
|
2016
Q3 | $10K | Buy |
+258
| New | +$5.69K | ﹤0.01% | 1036 |
|
SignatureFD's AERI Position: Q4 2022 in Review
SignatureFD sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 395 shares — an estimated $6K sold.
SignatureFD first reported a position in AERI in Q3 2016 and held it in 10 quarters. The position peaked at $10K in Q3 2016. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- SignatureFD reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- SignatureFD sold 395 Aerie Pharmaceuticals shares in Q4 2022, an estimated $6K.
- SignatureFD first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 10 quarters.
- SignatureFD's Aerie Pharmaceuticals position peaked at $10K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.